Posted in | News | Solar Energy | Sustainability

GlaxoSmithKline Installs Rooftop Solar System in North America

GlaxoSmithKline (GSK) Consumer Healthcare has begun the installation of a rooftop solar PV system, which is the largest in the North American region. The rooftop solar array is being installed on the company’s Northeast Distribution Center in Pennsylvania.

The total capacity of the PV system is 3 MW, and the system is expected to generate about 3.4 million kWh of electricity annually. The solar PV system will help the company to save 3000 tons of carbon dioxide emissions per year.

For the rooftop solar project, approximately 11,000 solar modules will be installed. The solar array will produce enough electricity to satisfy the energy needs of the entire building, which is about 500,000 sq. ft. Each solar module measures 6 x 3 ft., and weighs approximately 60 lbs. All the panels will be arranged in a grid system in sets, each set comprising three solar panels.

The solar installation project has been assigned to American Capital Energy, which has planned to install 500 solar panels every day. GSK received solar incentives, as well as, government funding for the project.

Because of such clean energy initiatives, GSK has been named the fifth greenest company of the world, in the 2010 Green Ranking of Newsweek. The President of GlaxoSmithKline Consumer Healthcare, John Clarke said that they hope other companies would be inspired by their initiatives to save the environment.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.